BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 33125945)

  • 1. A combined clinical and biological risk classification improves prediction of outcome in hepatoblastoma patients.
    Cairo S; Armengol C; Maibach R; Häberle B; Becker K; Carrillo-Reixach J; Guettier C; Vokuhl C; Schmid I; Buendia MA; Branchereau S; von Schweinitz D; Kappler R
    Eur J Cancer; 2020 Dec; 141():30-39. PubMed ID: 33125945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Children's Hepatic Tumors International Collaboration-Hepatoblastoma Stratification (CHIC-HS) System for Pediatric Patients with Hepatoblastoma: A Retrospective, Hospital-Based Cohort Study in South Korea.
    Kim PH; Shin HJ; Yoon HM; Choi YH; Namgoong JM; Kim DY; Koh KN; Lee MJ; Yoon H; Lyu CJ; Han JW; Hahn SM; Cho YA
    Cancer Res Treat; 2022 Jan; 54(1):253-258. PubMed ID: 33781052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The genomic landscape of hepatoblastoma and their progenies with HCC-like features.
    Eichenmüller M; Trippel F; Kreuder M; Beck A; Schwarzmayr T; Häberle B; Cairo S; Leuschner I; von Schweinitz D; Strom TM; Kappler R
    J Hepatol; 2014 Dec; 61(6):1312-20. PubMed ID: 25135868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel risk stratification model based on the Children's Hepatic Tumours International Collaboration-Hepatoblastoma Stratification and deoxyribonucleic acid methylation analysis for hepatoblastoma.
    Kondo T; Honda S; Suzuki H; Ito YM; Kawakita I; Okumura K; Ara M; Minato M; Kitagawa N; Tanaka Y; Tanaka M; Shinkai M; Hishiki T; Watanabe K; Ida K; Takatori A; Hiyama E; Taketomi A
    Eur J Cancer; 2022 Sep; 172():311-322. PubMed ID: 35816972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small Cell Undifferentiated Histology Does Not Adversely Affect Outcome in Hepatoblastoma: A Report From the Children's Oncology Group (COG) AHEP0731 Study Committee.
    Trobaugh-Lotrario A; Katzenstein HM; Ranganathan S; Lopez-Terrada D; Krailo MD; Piao J; Chung N; Randazzo J; Malogolowkin MH; Furman WL; McCarville EB; Towbin AJ; Tiao GM; Dunn SP; Langham MR; McGahren ED; Feusner J; Rodriguez-Galindo C; Meyers RL; O'Neill AF; Finegold MJ
    J Clin Oncol; 2022 Feb; 40(5):459-467. PubMed ID: 34874751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications.
    Carrillo-Reixach J; Torrens L; Simon-Coma M; Royo L; Domingo-Sàbat M; Abril-Fornaguera J; Akers N; Sala M; Ragull S; Arnal M; Villalmanzo N; Cairo S; Villanueva A; Kappler R; Garrido M; Guerra L; Sábado C; Guillén G; Mallo M; Piñeyro D; Vázquez-Vitali M; Kuchuk O; Mateos ME; Ramírez G; Santamaría ML; Mozo Y; Soriano A; Grotzer M; Branchereau S; de Andoin NG; López-Ibor B; López-Almaraz R; Salinas JA; Torres B; Hernández F; Uriz JJ; Fabre M; Blanco J; Paris C; Bajčiová V; Laureys G; Masnou H; Clos A; Belendez C; Guettier C; Sumoy L; Planas R; Jordà M; Nonell L; Czauderna P; Morland B; Sia D; Losic B; Buendia MA; Sarrias MR; Llovet JM; Armengol C
    J Hepatol; 2020 Aug; 73(2):328-341. PubMed ID: 32240714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pure fetal histology subtype was associated with better prognosis of children with hepatoblastoma: A Chinese population-based study.
    Qiao GL; Chen Z; Wang C; Ge J; Zhang Z; Li L; Ren J
    J Gastroenterol Hepatol; 2016 Mar; 31(3):621-7. PubMed ID: 26401976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent improvement in survival outcomes and reappraisal of prognostic factors in hepatoblastoma.
    Koh KN; Namgoong JM; Yoon HM; Cho YA; Choi SH; Shin J; Kang SH; Suh JK; Kim H; Oh SH; Kim KM; Kim DY; Im HJ
    Cancer Med; 2021 May; 10(10):3261-3273. PubMed ID: 33939313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Independent Assessment of the Children's Hepatic Tumors International Collaboration Risk Stratification for Hepatoblastoma and the Association of Tumor Histological Characteristics With Prognosis.
    Zhou S; Malvar J; Chi YY; Stein J; Wang L; Genyk Y; Sposto R; Mascarenhas L
    JAMA Netw Open; 2022 Feb; 5(2):e2148013. PubMed ID: 35147687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High expression of IGF2-derived intronic miR-483 predicts outcome in hepatoblastoma.
    Weiss JBW; Wagner AE; Eberherr C; Häberle B; Vokuhl C; von Schweinitz D; Kappler R
    Cancer Biomark; 2020; 28(3):321-328. PubMed ID: 32390604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children's Hepatic tumors International Collaboration.
    Meyers RL; Maibach R; Hiyama E; Häberle B; Krailo M; Rangaswami A; Aronson DC; Malogolowkin MH; Perilongo G; von Schweinitz D; Ansari M; Lopez-Terrada D; Tanaka Y; Alaggio R; Leuschner I; Hishiki T; Schmid I; Watanabe K; Yoshimura K; Feng Y; Rinaldi E; Saraceno D; Derosa M; Czauderna P
    Lancet Oncol; 2017 Jan; 18(1):122-131. PubMed ID: 27884679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment outcomes and prognostic factors in children with hepatoblastoma using a risk-stratified approach.
    Srinivasan S; Prasad M; Parambil BC; Shrimal A; Gollamudi VRM; Subramani V; Ramadwar M; Khanna N; Baheti AD; Gala K; Patil V; Laskar S; Qureshi S; Chinnaswamy G
    Pediatr Blood Cancer; 2023 Jul; 70(7):e30302. PubMed ID: 37046413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Children's Hepatic tumors International Collaboration (CHIC): Novel global rare tumor database yields new prognostic factors in hepatoblastoma and becomes a research model.
    Czauderna P; Haeberle B; Hiyama E; Rangaswami A; Krailo M; Maibach R; Rinaldi E; Feng Y; Aronson D; Malogolowkin M; Yoshimura K; Leuschner I; Lopez-Terrada D; Hishiki T; Perilongo G; von Schweinitz D; Schmid I; Watanabe K; Derosa M; Meyers R
    Eur J Cancer; 2016 Jan; 52():92-101. PubMed ID: 26655560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant expression of cancer stem cell markers (CD44, CD90, and CD133) contributes to disease progression and reduced survival in hepatoblastoma patients: 4-year survival data.
    Bahnassy AA; Fawzy M; El-Wakil M; Zekri AR; Abdel-Sayed A; Sheta M
    Transl Res; 2015 Mar; 165(3):396-406. PubMed ID: 25168019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment outcome and pattern of failure in hepatoblastoma treated with a consensus protocol in Hong Kong.
    Liu APY; Ip JJK; Leung AWK; Luk CW; Li CH; Ho KKH; Lo R; Chan EKW; Chan ACY; Chung PHY; Chiang AKS
    Pediatr Blood Cancer; 2019 Jan; 66(1):e27482. PubMed ID: 30270490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights into diagnosis and therapeutic options for proliferative hepatoblastoma.
    Hooks KB; Audoux J; Fazli H; Lesjean S; Ernault T; Dugot-Senant N; Leste-Lasserre T; Hagedorn M; Rousseau B; Danet C; Branchereau S; Brugières L; Taque S; Guettier C; Fabre M; Rullier A; Buendia MA; Commes T; Grosset CF; Raymond AA
    Hepatology; 2018 Jul; 68(1):89-102. PubMed ID: 29152775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis predicts survival following neo-adjuvant chemotherapy for hepatoblastoma.
    Venkatramani R; Wang L; Malvar J; Dias D; Sposto R; Malogolowkin MH; Mascarenhas L
    Pediatr Blood Cancer; 2012 Sep; 59(3):493-8. PubMed ID: 22190448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new risk-stratification system for hepatoblastoma in children under six years old and the significance for prognosis evaluation-a 14-year retrospective study from a single center.
    Zhi T; Zhang WL; Zhang Y; Hu HM; Wang YZ; Huang DS
    BMC Cancer; 2021 Apr; 21(1):397. PubMed ID: 33849485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic and predictive biomarkers in paediatric solid tumours.
    Glembocki AI; Somers GR
    Pathology; 2024 Mar; 56(2):283-296. PubMed ID: 38216399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The importance of age as prognostic factor for the outcome of patients with hepatoblastoma: Analysis from the Children's Hepatic tumors International Collaboration (CHIC) database.
    Haeberle B; Rangaswami A; Krailo M; Czauderna P; Hiyama E; Maibach R; Lopez-Terrada D; Aronson DC; Alaggio R; Ansari M; Malogolowkin MH; Perilongo G; O'Neill AF; Trobaugh-Lotrario AD; Watanabe K; Schmid I; von Schweinitz D; Ranganathan S; Yoshimura K; Hishiki T; Tanaka Y; Piao J; Feng Y; Rinaldi E; Saraceno D; Derosa M; Meyers RL
    Pediatr Blood Cancer; 2020 Aug; 67(8):e28350. PubMed ID: 32383794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.